Dividend 15 Split Corp. Completes Exchange Offer and Preferred Share Offering
A high quality portfolio consisting of 15 dividend yielding Canadian Companies
TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. (the “Company”) is pleased to announce it has issued 1,114,478 Preferred Shares and 1,114,478 Class A shares of the Company. The shares will trade on the Toronto Stock Exchange under the existing symbols of DFN.PR.A (Preferred Shares) and DFN (Class A Shares).
Under the Exchange Offer announced on June 7, 2018, the Company offered 5.55 Class A Shares in exchange for each of 133,327 freely-tradable common shares of BCE Inc. and 5.55 Class A Shares for each of 67,480 freely-tradable common shares of TransCanada Corporation. In conjunction with the Exchange Offer, the Company also issued Preferred Shares. The total combined gross proceeds were $22.2 million, bringing the Company’s net assets to approximately $818.6 million.
The Company currently holds 936,800 shares of BCE Inc. and 1,013,400 shares of TransCanada Corporation in its investment portfolio and the shares taken up in this exchange will be added to the portfolio for investment purposes only.
The Company’s investment portfolio is an actively managed, high quality portfolio consisting of 15 dividend yielding Canadian companies as follows:
Bank of Montreal
Bank of Nova Scotia
BCE Inc.
CI Financial Corp.
CIBC
Enbridge Inc.
Manulife Financial
National Bank of Canada
Royal Bank
Sun Life Financial
TELUS Corporation
Thomson Reuters Corporation
Toronto-Dominion Bank
TransAlta Corporation
TransCanada Corporation
For further information, please contact Dividend 15 Split Corp. Investor Relations at
416-304-4443 Toll free at 1-877-4-Quadra (1-877-478-2372) or visit www.dividend15.com
Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Investors should read theprospectus supplement to the Company’s short form base shelf prospectus dated November 2, 2017 before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. Please read the Company’s publically filed documents which are available at www.sedar.com.
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Aptinyx (Nasdaq: APTX) Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder (PTSD)
